Literature DB >> 8641566

Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24).

S C Wright1, H Zheng, J Zhong.   

Abstract

Signal transduction pathways involved in apoptotic cell death are poorly understood, although recent studies have implicated sphingomyelin hydrolysis and generation of the second messenger, ceramide. Previous work in this laboratory demonstrated that a serine protease termed AP24 was activated by TNF or UV light and induced DNA fragmentation in isolated nuclei. This study extended these findings to examine the role of these enzymes in apoptosis of the U937 cell line and the mechanism of resistance of its variant, U9-TR. Although this subclone was selected by growth in TNF, it was unexpectedly found to resist apoptosis induced by UV light, but was still sensitive to anti-Fas-induced DNA fragmentation. Here we show that in contrast to normal U937 cells, UV light and TNF both failed to activate neutral or acidic sphingomyelinase or AP24 in the U9-TR variant. However, anti-Fas activated both neutral and acidic sphingomyelinase in the variant comparable to that seen in parental U937. The U9-TR variant could be sensitized to TNF or UV light activation of both sphingomyelinase and DNA fragmentation by the protein phosphatase inhibitors okadaic acid and calyculin A. Furthermore, exogenous bacterial-derived sphingomyelinase caused U9-TR activation of AP24 and DNA fragmentation comparable to that in the parental U937. Exposure of permeabilized U937 cells to ceramide caused internucleosomal DNA cleavage that was blocked by an inhibitor of AP24. Taken altogether, these findings demonstrate that TNF or UV light activate sphingomyelinase that leads to the generation of ceramide resulting in activation of AP24 and DNA fragmentation in sensitive cells. A selective defect in signals leading to sphingomyelinase activation can confer resistance to apoptosis even though the variant is still sensitive to downstream apoptotic signals such as nuclear DNA fragmentation by activated exogenous AP24.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641566     DOI: 10.1096/fasebj.10.2.8641566

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

Review 1.  Non-caspase proteases: triggers or amplifiers of apoptosis?

Authors:  Karen Schrader; Jisen Huai; Lars Jöckel; Carolin Oberle; Christoph Borner
Journal:  Cell Mol Life Sci       Date:  2010-02-19       Impact factor: 9.261

2.  Fas-induced apoptosis of T cells occurs independently of ceramide generation.

Authors:  J D Watts; M Gu; A J Polverino; S D Patterson; R Aebersold
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.

Authors:  J Tohyama; Y Oya; T Ezoe; M T Vanier; H Nakayasu; N Fujita; K Suzuki
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

4.  Evidence against an early signalling role for ceramide in Fas-mediated apoptosis.

Authors:  D J Sillence; D Allan
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

5.  Nitric oxide inhibits tumor necrosis factor-alpha-induced apoptosis by reducing the generation of ceramide.

Authors:  C De Nadai; P Sestili; O Cantoni; J P Lièvremont; C Sciorati; R Barsacchi; S Moncada; J Meldolesi; E Clementi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 6.  Ceramide in apoptosis: a revisited role.

Authors:  Thierry Levade; Sophie Malagarie-Cazenave; Valérie Gouazé; Bruno Ségui; Claudine Tardy; Susan Betito; Nathalie Andrieu-Abadie; Olivier Cuvillier
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

7.  Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells.

Authors:  Gauri A Patwardhan; Salman B Hosain; David X Liu; Sachin K Khiste; Yunfeng Zhao; Jacek Bielawski; S Michal Jazwinski; Yong-Yu Liu
Journal:  Biochim Biophys Acta       Date:  2014-09-06

8.  Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity.

Authors:  S C Wright; U Schellenberger; H Wang; D H Kinder; J W Talhouk; J W Larrick
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

9.  Gentamicin arrests cancer cell growth: the intriguing involvement of nuclear sphingomyelin metabolism.

Authors:  Michela Codini; Samuela Cataldi; Francesco Saverio Ambesi-Impiombato; Andrea Lazzarini; Alessandro Floridi; Remo Lazzarini; Francesco Curcio; Tommaso Beccari; Elisabetta Albi
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

10.  P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest.

Authors:  A A Shamseddine; C J Clarke; B Carroll; M V Airola; S Mohammed; A Rella; L M Obeid; Y A Hannun
Journal:  Cell Death Dis       Date:  2015-10-29       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.